Long-acting muscarinic M3 receptor antagonists -: GlaxoSmithKline

被引：5
|
作者：
Norman, Peter [1 ]
机构：
[1] Norman Consulting, Burnham SL1 8JW, Bucks, England
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2006年 / 16卷 / 09期
关键词：
bronchodilator; COPD; M-3; receptor; muscarinic antagonist; urinary incontinence;
D O I：
10.1517/13543776.16.9.1315
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two applications claim a novel class of muscarinic M-3 receptor antagonists and their use as long-acting agents for the treatment of chronic obstructive pulmonary disease. The two applications claim closely related structures with one claiming quaternary amine salts of the tertiary amines claimed in the other. The claimed compounds comprise a biarylmethylamine core with the amino group modified by acylation or sulfonation and a tertiary or quaternary amine coupled to the distal ring of the biaryl system.
引用
收藏
页码：1315 / 1320
页数：6
相关论文
共 50 条
  • [41] Comparison Of The Pharmacological Profile Of Long-Acting Muscarinic Antagonists On Isolated Human Bronchi
    Naline, E.
    Delyle, S. Grassin
    Salvator, H.
    Devillier, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [42] Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus
    Naline, Emmanuel
    Delyle, Stanislas Grassin
    Salvator, Helene
    Brollo, Marion
    Faisy, Christophe
    Victoni, Tatiana
    Abrial, Charlotte
    Devillier, Philippe
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 46 - 53
  • [43] Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs
    Casarosa, Paola
    Bouyssou, Thierry
    Germeyer, Sabine
    Schnapp, Andreas
    Gantner, Florian
    Pieper, Michael
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (02): : 660 - 668
  • [44] Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease
    Jones, Paul W.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (03) : 84 - 96
  • [45] Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
    Busse, William W.
    Dahl, Ronald
    Jenkins, Christine
    Cruz, Alvaro A.
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (139): : 54 - 64
  • [46] Medicinal Chemistry and Therapeutic Potential of Muscarinic M3 Antagonists
    Peretto, Ilaria
    Petrillo, Paola
    Imbimbo, Bruno P.
    MEDICINAL RESEARCH REVIEWS, 2009, 29 (06) : 867 - 902
  • [47] Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study
    Jusufovic, Edin
    Zugic, Vladimir
    Kosnik, Mitja
    Drvenica, Mirjana Jovancevic
    Hromis, Sanja
    Nurkic, Jasmina
    Al-Ahmad, Mona
    Kardum, Ljiljana Bulat
    Sejdinovic, Rifat
    Prnjavorac, Besim
    Jusufovic, Azra
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [48] Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town
    Hamelmann E.
    Allergo Journal International, 2018, 27 (7) : 220 - 227
  • [49] 1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists
    Sonda, Shuji
    Katayama, Kenichi
    Fujio, Masakazu
    Sakashita, Hiroshi
    Inaba, Kenichi
    Asano, Kiyoshi
    Akira, Toshiaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (04) : 925 - 931
  • [50] Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020-2023
    Matera, Maria Gabriella
    Calzetta, Luigino
    Rogliani, Paola
    Cazzola, Mario
    Hanania, Nicola
    LUNG, 2024, 202 (02) : 119 - 125
12345